Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00688935 · ClinicalTrials.gov registry record · NA

Young Blind Child Melatonin Treatment Study

A NA study, sponsored by Oregon Health and Science University.

Terminated
Registry status
NA
Development phase
9
Enrollment target

NCT00688935: Clinical Trial NA study, sponsored by Oregon Health and Science University.

NCT00688935 is a NA study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00688935, a NA study, was terminated before completion, sponsored by Oregon Health and Science University.

TERMINATED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

The primary goal of this study is to identify the presence of desynchronized circadian rhythms in 25 children by measuring melatonin secretion in serial blood or saliva samples, and to rule out any primary sleep disorders.

Interventions

  • BIOLOGICAL Melatonin

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2005-01
Est. Completion 2015-05
Phase NA

Why NCT00688935 stopped before completion

NCT00688935 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Melatonin is the first listed.

NCT00688935 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00688935 about?

NCT00688935 is a clinical study titled "Young Blind Child Melatonin Treatment Study". The primary goal of this study is to identify the presence of desynchronized circadian rhythms in 25 children by measuring melatonin secretion in serial blood or saliva samples, and to rule out any primary sleep disorders.

What is the current status of trial NCT00688935?

This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2005-01. Estimated completion is 2015-05.

What interventions are being tested in trial NCT00688935?

The interventions under investigation include: Melatonin (BIOLOGICAL).

Who is sponsoring clinical trial NCT00688935?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00688935's enrollment target sits among peer trials

9 1975th of 2000 higher than 25 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00688935, the US trial registry maintained by the National Library of Medicine. NCT00688935 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.